BPC-157-TB-500 blend

This blend vial contains BPC-157 (and TB-500 in a single lyophilized preparation. These peptides have distinct molecular mechanisms and signaling characteristics. BPC-157 interacts with VEGFR2-, ERK1/2-, eNOS-, and FAK-associated signaling networks and regulates extracellular protein systems. TB-500, a synthetic analogue of Thymosin Beta-4, regulates actin-associated processes by binding to G-actin through the LKKTET motif, influencing cytoskeletal organization and signaling pathways. Experimental investigations have examined both compounds across various peptide-mediated regulatory systems. The blend simplifies the reconstitution process in multi-peptide study designs and allows researchers to investigate comparative or concurrent peptide-signaling mechanisms. Each peptide retains its individual chemical identity and pharmacological profile. The blend has been independently third-party HPLC-tested.

This description summarises how the compound is used in published laboratory research. It is not a claim of efficacy, safety or suitability for any purpose.

Form

Lyophilized white powder

Purity

≥99% (HPLC)

Presentations

5/5 mg · 10/10 mg

Reference lot

AB-HR-WOLVERINE10

Storage

Lyophilized: store at −20 °C, protected from light. Reconstituted: 2–8 °C.

Reconstitution

Reconstitute with bacteriostatic water. Swirl; do not shake. Do not vortex.